Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence

AIDS Research and Human Retroviruses

Volumn 30, Issue 1, 2014, Pages 29-36

  Moyo, Sikhulile ^a,b   LeCuyer, Tessa ^a,c   Wang, Rui ^d,e   Gaseitsiwe, Simani ^a,d   Weng, Jia ^e   Musonda, Rosemary ^a,d   Bussmann, Hermann ^a,d   Mine, Madisa ^a,f   Engelbrecht, Susan ^b,g   Makhema, Joseph ^a,d   Marlink, Richard ^a,d   Baum, Marianna K ^h   Novitsky, Vladimir ^a,d   Essex, M ^a,d  

^a BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f National Health Laboratory and Botswana Harvard HIV Reference Laboratory   (Botswana)

^g NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^h FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BOTSWANA; CD4 LYMPHOCYTE COUNT; CLASSIFICATION ALGORITHM; COHORT ANALYSIS; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 (STRAIN C); HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS LOAD; YOUNG ADULT; ALGORITHM; BLOOD; CLASSIFICATION; GEOGRAPHY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; INCIDENCE; PREGNANCY; PROSPECTIVE STUDY;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ALGORITHMS; BOTSWANA; CD4 LYMPHOCYTE COUNT; FEMALE; GEOGRAPHY; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; MALE; PREGNANCY; PROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84891803931     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2013.0055     Document Type: Article

References (44)

1. De Gruttola V and Lagakos SW: The value of AIDS incidence data in assessing the spread of HIV infection. Stat Med 1989;8:35-43.
2. Fiamma A, Lissouba P, Amy OE, Singh B, Laeyendecker O, Quinn TC, Taljaard D, and Auvert B: Can HIV incidence testing be used for evaluating HIV intervention programs? A reanalysis of the Orange Farm male circumcision trial (ANRS-1265). BMC Infect Dis 2010;10:137.
3. Brookmeyer R: Measuring the HIV/AIDS epidemic: Approaches and challenges. Epidemiol Rev 2010;32:26-37.
4. Hallett TB: Estimating the HIV incidence rate: Recent and future developments. Curr Opin HIV AIDS 2011;6:102-107.
5. Incidence Assay Critical Path Working Group: More and better information to tackle HIV epidemics: Towards improved HIV incidence assays. PLoS Med 2011;8:e1001045.
6. Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, and Choopanya K: Quantitative detection of increasing HIV type 1 antibodies after seroconversion: A simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses 2002;18:295-307.
7. Brookmeyer R and Quinn TC: Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995;141: 166-172.
8. Wei X, Liu X, Dobbs T, Kuehl D, Nkengasong JN, Hu DJ, and Parekh BS: Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein. AIDS Res Hum Retroviruses 2010;26:61-71.
9. Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, Oluoch T, and Garcia-Calleja JM: Estimating HIV incidence in populations using tests for recent infection: Issues, challenges and the way forward. J HIV AIDS Surveill Epidemiol 2010;2:1.
10. McDougal JS, Parekh BS, Peterson ML, Branson BM, Dobbs T, Ackers M, and Gurwith M: Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retroviruses 2006;22:945-952.
11. Brown T, Bao L, Raftery AE, Salomon JA, Baggaley RF, Stover J, and Gerland P: Modelling HIV epidemics in the antiretroviral era: The UNAIDS Estimation and Projection package 2009. Sex Transm Infect 2010;86(Suppl 2):ii3-10.
12. Ghys PD, Brown T, Grassly NC, Garnett G, Stanecki KA, Stover J, and Walker N: The UNAIDS Estimation and Projection Package: A software package to estimate and project national HIV epidemics. Sex Transm Infect 2004;80(Suppl 1): i5-9.
13. Welte A, McWalter TA, Laeyendecker O, and Hallett TB: Using tests for recent infection to estimate incidence: problems and prospects for HIV. Euro Surveill 2010;15.
14. Truong HM, Kellogg T, Louie B, Klausner J, Dilley J, and McFarland W: Recent HIV-1 infection detection: Comparison of incidence estimates derived by laboratory assays and repeat testing data. J Acquir Immune Defic Syndr 2009;51:502-505.
15. Barnighausen T, Wallrauch C, Welte A, McWalter TA, Mbizana N, Viljoen J, Graham N, Tanser F, Puren A, and Newell ML: HIV incidence in rural South Africa: Comparison of estimates from longitudinal surveillance and crosssectional cBED assay testing. PLoS One 2008;3:e3640.
16. Karita E, Price M, Hunter E, Chomba E, Allen S, Fei L, Kamali A, Sanders EJ, Anzala O, and Katende M: Investigating the utility of the HIV-1 BED capture enzyme immunoassay using cross-sectional and longitudinal seroconverter specimens from Africa. AIDS 2007;21:403.
17. Shah N LL, Ha H, Quang P, Cuc C, Kim A, Duong Y, Parekh B, Lien T, and Tuan N: Evaluating the accuracy of the BED capture enzyme immunoassay and rlDRM limiting antigen avidity assay in detecting long-term infection in a sample of persons with known chronic HIV infections in Vietnam. 8th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2011.
18. Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, Rehle T, Hargrove J, Remis RS, and Kaldor JM: Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: A systematic review. Lancet Infect Dis 2009;9:747-759.
19. Marinda ET, Hargrove J, Preiser W, Slabbert H, van Zyl G, Levin J, Moulton LH, Welte A, and Humphrey J: Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy. J Acquir Immune Defic Syndr 2010;53:496-499.
20. World Health Organization: When and How to Use Assays for Recent Infection to Estimate HIV Incidence at a Population Level. WHO Press, Geneva, 2011.
21. Hargrove J and Humphrey J: Simplified estimation of the long-term specificity of the BED assay to improve estimates of HIV incidence. AIDS Res Hum Retroviruses 2010;26:977-979.
22. Hargrove JW, Humphrey JH, Mutasa K, Parekh BS, McDougal JS, Ntozini R, Chidawanyika H, Moulton LH, Ward B, Nathoo K, Iliff PJ, and Kopp E: Improved HIV-1 incidence estimates using the BED capture enzyme immunoassay. AIDS 2008;22:511-518.
23. Kim AA, Hallett T, Stover J, Gouws E, Musinguzi J, Mureithi PK, Bunnell R, Hargrove J, Mermin J, Kaiser RK, Barsigo A, and Ghys PD: Estimating HIV Incidence among adults in Kenya and Uganda: A systematic comparison of multiple methods. PLoS One 2011;6:e17535.
24. Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH for the Multicenter Aids Cohort Study Macs: Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses 2012;28:816-822.
25. Hallett TB, Ghys P, Barnighausen T, Yan P, and Garnett GP: Errors in 'BED'-derived estimates of HIV incidence will vary by place, time and age. PLoS One 2009;4:e5720.
26. Wang R and Lagakos SW: On the use of adjusted crosssectional estimators of HIV incidence. J Acquir Immune Defic Syndr 2009;52:538-547.
27. Braunstein SL, Nash D, Kim AA, Ford K, Mwambarangwe L, Ingabire CM, Vyankandondera J, and van de Wijgert JH: Dual testing algorithm of BED-CEIA and AxSYM Avidity Index assays performs best in identifying recent HIV infection in a sample of Rwandan sex workers. PLoS One 2011;6:e18402.
28. Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, and Eshleman SH: Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known nonrecent HIV infection from five African countries. AIDS Res Hum Retroviruses 2012;28:1177-1183.
29. Chawla A, Murphy G, Donnelly C, Booth C, Johnson M, Parry J, Phillips A, and Geretti A: Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol 2007;45:415-420.
30. Novitsky V, Wang R, Bussmann H, Lockman S, Baum M, Shapiro R, Thior I, Wester C, Wester CW, Ogwu A, Asmelash A, Musonda R, Campa A, Moyo S, van Widenfelt E, Mine M, Moffat C, Mmalane M, Makhema J, Marlink R, Gilbert P, Seage GR, 3rd, DeGruttola V, and Essex M: HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and- treat" approach to reduce HIV transmission. PLoS One 2010;5:e10148.
31. Baum M, Campa A, Lai S, Sales S, Li Y, Burns P, Bussmann H, Moyo S, Widenfelt E, Thior I, Tsalaile L, Makhema J, Fawzi W, Essex M, Marlink R, and the Dikotlana Study Team: Micronutrient supplementation to prevent disease progression in HIV infected adults in Botswana. AIDS 2010 - XVIII International AIDS Conference, Mexico City, Mexico. Abstract no. MOPE0100 2010.
32. Baum M, Le K, Moyo S, Makhema J, Burns P, Sales S, Tsalaile L, Bussmann H, Li Y, and Campa A: Dietary fat intake, liver function and disease progression in HIV + adults in Botswana, Africa. FASEB J 2009;23:722-723.
33. Dobbs T, Kennedy S, Pau CP, McDougal JS, and Parekh BS: Performance characteristics of the immunoglobulin G-capture BED-enzyme immunoassay, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 2004;42:2623-2628.
34. Masciotra S, Dobbs T, Candal D, Hanson D, Delaney K, and Rudolph D: Antibody avidity-based assay for identifying recent HIV-1 infections based on Genetic Systems TM 1/2 plus O EIA. Paper presented at the Conference on Retroviruses and Opportunistic Infections 2010, San Francisco, 2010.
35. Chen PL, Bernholc A, Chipato T, Laeyendecker O, Salata R, and Morrison C: Dual testing algorithms of BED-CEIA and BioRad +O EIA avidity assays in evaluating HIV-1 falserecent misclassification in a longitudinal sample of African women. Paper presented at the 19th International AIDS Conference, 2012,Washington, DC.
36. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, and Busch MP: Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871-1879.
37. Calypte Biomedical Corporation: Aware(TM) BED(TM) EIA HIV-1 Incidence (IgG-Capture HIV-EIA) Enzyme Immunoassay for Population Estimates of HIV-1 Incidence. Portland, OR, 2008.
38. Laeyendecker O, Brookmeyer R, Mullis C, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, and Eshleman S: Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known non-recent HIV infection from five African countries. AIDS Res Hum Retroviruses 2012;28:1177-1183.
39. Xiao Y, Jiang Y, Feng J, Xu W, Wang M, Funkhouser E, Vermund SH, and Jia Y: Seroincidence of recent human immunodeficiency virus type 1 infections in China. Clin Vaccine Immunol 2007;14:1384-1386.
40. Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR, 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, and Eshleman SH: HIV incidence determination in the United States: A multiassay approach. J Infect Dis 2013;207:232-239.
41. Brookmeyer R: Should biomarker estimates of HIV incidence be adjusted? AIDS 2009;23:485-491.
42. Wang R and Lagakos SW: Augmented cross-sectional prevalence testing for estimating HIV incidence. Biometrics 2010;66:864-874.
43. Brookmeyer R and Gail M: AIDS epidemiology: A quantitative approach. Monographs Epidemiol Biostat 1994;22:ix.
44. Hargrove J, van Schalkwyk C, and Eastwood H: Bed estimates of HIV incidence: Resolving the differences, making things simpler. PLoS One 2012;7:e29736.